← All companies
Telix Pharmaceuticals Ltd
TLX - CIK 0002007191
Market cap$3.20 B
Rank#1751
SEC filings95
Telix Pharmaceuticals Ltd trades as TLX and has a market capitalization of $3.20 B, making it the #1751 largest US-listed company by market value. This page tracks Telix Pharmaceuticals Ltd through 95 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Total assets (latest FY)$1.16BFY 2025
Key statistics
- Market cap
- $3.20 B
- Share price (derived)market cap / shares outstanding
- $9.46
- Shares outstandingas of 2025-12-31
- 0.34B
- R&D expenseFY 2025
- $171.25M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-21 |
| New insider ownership | 3 | 2026-05-18 |
| New insider ownership | 3 | 2026-05-18 |
| New insider ownership | 3 | 2026-05-18 |
| Insider trade | 4 | 2026-05-06 |
| 6-K | - | 2026-04-23 |
| 6-K | - | 2026-04-21 |
| 6-K | - | 2026-04-20 |
Recent press releases
- Half-year & Quarterly Results2026-05-27
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences
- IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing - 18 May 20262026-05-19
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
- Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches - 15 May 20262026-05-15
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Similar companies
The largest companies sharing Telix Pharmaceuticals Ltd's SEC industry classification (pharmaceutical preparations).
Frequently asked questions
What is Telix Pharmaceuticals Ltd's market cap?
Telix Pharmaceuticals Ltd (TLX) has a market capitalization of $3.20 B as of 2026-06-10, ranking #1751 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.